GLP-1 receptor agonists are already widely used for their ability to reduce appetite, slow gastric emptying, and improve glycemic control, leading to marked weight loss in patients with obesity and type 2 diabetes [191]. The gene discussed is GLP1R; the disease is obesity disorder.